Contraindicated (1)bortezomib will boost the degree or influence of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Powerful or moderate CYP2C19 inhibitors may possibly maximize mavacamten systemic publicity, leading to coronary heart failure due to systolic dysfunction. fluconazole will raise the amount or result of bortezomib by impacting hepatic/intest... https://fredv000htd3.scrappingwiki.com/user